Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Assured Guaranty
AGO
$3.36B
| $21M | 0.05% |
857,800
-403,328
| -32% | -$10M |
|
452
Chunghwa Telecom
CHT
$32.8B
| $21M | 0.05% |
655,184
+64,401
| +11% | +$2.03M |
|
453
Western Digital
WDC
$167B
| $21M | 0.05% |
300,718
-47,099
| -14% | -$3.16M |
|
|
XLS
454
DELISTED
EXELIS INC COM STK
XLS
| $20.9M | 0.05% |
1,321,293
+292,812
| +28% | +$4.83M |
|
455
Campbell Soup
CPB
$6.94B
| $20.9M | 0.05% |
456,600
-636,500
| -58% | -$28.7M |
|
456
Herbalife
HLF
$1.27B
| $20.9M | 0.05% |
648,200
-629,000
| -49% | -$19.3M |
|
|
EQC
457
DELISTED
Equity Commonwealth
EQC
| $20.9M | 0.05% |
794,375
+462,500
| +139% | +$12.2M |
|
|
BPY
458
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $20.9M | 0.05% |
1,001,184
-150,409
| -13% | -$3M |
|
|
INVX
459
Innovex International
INVX
$2.15B
| $20.8M | 0.05% |
190,500
-302,887
| -61% | -$32.6M |
|
|
BCPC
460
Balchem Corp
BCPC
$5.65B
| $20.6M | 0.05% |
385,400
+46,663
| +14% | +$2.68M |
|
461
Willis Towers Watson
WTW
$31.1B
| $20.6M | 0.05% |
179,503
+76,218
| +74% | +$8.57M |
|
|
WPZ
462
DELISTED
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
| $20.5M | 0.05% |
+401,210
| New | +$19.8M |
|
463
Unisys
UIS
$210M
| $20.5M | 0.05% |
828,090
-50,600
| -6% | -$1.28M |
|
464
DaVita
DVA
$11.5B
| $20.4M | 0.05% |
282,500
+138,372
| +96% | +$9.62M |
|
|
GAME
465
DELISTED
SHANDA GAMES LTD SPON ADR REPSTG CL A (CAYMAN ISLANDS)
GAME
| $20.4M | 0.05% |
3,071,890
+1,450,345
| +89% | +$9.65M |
|
466
American Water Works
AWK
$27.1B
| $20.4M | 0.05% |
412,400
-157,001
| -28% | -$7.38M |
|
467
Pitney Bowes
PBI
$2.29B
| $20.4M | 0.05% |
737,200
-403,800
| -35% | -$10.8M |
|
468
FirstEnergy
FE
$27.1B
| $20.3M | 0.05% |
585,808
-208,900
| -26% | -$7.03M |
|
469
Hexcel
HXL
$7.72B
| $20.3M | 0.05% |
496,200
+352,999
| +247% | +$14.7M |
|
470
Monolithic Power Systems
MPWR
$67.3B
| $20.3M | 0.05% |
478,286
-43,200
| -8% | -$1.67M |
|
|
SIX
471
DELISTED
Six Flags Entertainment Corp.
SIX
| $20.2M | 0.05% |
475,800
-346,200
| -42% | -$14.1M |
|
472
Idexx Laboratories
IDXX
$44.6B
| $20.2M | 0.05% |
302,800
+185,000
| +157% | +$11.8M |
|
|
AVP
473
DELISTED
Avon Products, Inc.
AVP
| $20.1M | 0.05% |
1,375,200
-2,301,346
| -63% | -$33.2M |
|
474
Comscore
SCOR
$90.1M
| $20M | 0.05% |
28,190
-3,966
| -12% | -$2.55M |
|
475
Gildan
GIL
$10.5B
| $20M | 0.05% |
679,200
-148,600
| -18% | -$3.97M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.